{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:48:58Z","timestamp":1793810938422,"version":"4.6.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Japan Hip Joint Foundation"},{"name":"Japan Hip Joint Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study evaluates the efficacy of administering platelet-rich plasma (PRP) compared to hyaluronic acid (HA) for pain management hip osteoarthritis (OA) secondary to developmental dysplasia of the hip (DDH). It highlights PRP treatment as a slightly more effective or equivalent treatment for reducing hip pain in such cases. From 2019 to 2021, a double-blind, randomized controlled trial was conducted with 42 patients who consented to participate. They were divided into two groups: one receiving intra-articular PRP injections and the other HA injections. The primary focus of the study was pain relief, measured using the pain-Visual Analogue Scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)-pain scores over a 24-week period. Functionality was assessed as a secondary outcome. The results showed significant pain reduction in both PRP and HA groups compared to their baseline pain levels. Notably, the PRP treatment group exhibited a marginally higher improvement in pain-VAS scores (38.5) than the HA group (18.7; P\u2009=\u2009.041). However, the difference in WOMAC-pain scores between the groups was not statistically significant (4.3 for PRP vs. 2.9 for HA; P\u2009=\u2009.245). The Kellgren\u2013Lawrence grade was the only factor significantly associated with the improvement in pain-VAS scores within the PRP group. The study finds that PRP treatment is at least as effective as HA treatment in reducing hip pain for OA secondary to DDH. Treatment with PRP showed notably better pain-VAS scores compared to HA, highlighting its potential. Therefore, intra-articular PRP injections are a viable alternative to HA for effectively reducing pain in OA secondary to DDH.<\/jats:p>","DOI":"10.1093\/jhps\/hnaf008","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T23:18:36Z","timestamp":1740698316000},"page":"230-236","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of platelet-rich plasma in pain management of osteoarthritis with developmental dysplasia of the hip: a double-blind, randomized controlled trial"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-7770","authenticated-orcid":false,"given":"Yusuke","family":"Okanoue","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Kochi Medical School , Nankoku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Ikeuchi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Kochi Medical School , Nankoku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Dan","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Kochi Medical School , Nankoku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Teranishi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Kochi Medical School , Nankoku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"2025121807520361800_R1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"2025121807520361800_R2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2106\/JBJS.O.00109","article-title":"Hip dysplasia in the young adult","volume":"98","author":"Gala","year":"2016","journal-title":"J Bone Joint Surg Am"},{"key":"2025121807520361800_R3","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.arth.2017.02.067","article-title":"A contemporary definition of hip dysplasia and structural instability: toward a comprehensive classification for acetabular dysplasia","volume":"32","author":"Wilkin","year":"2017","journal-title":"J Arthroplasty"},{"key":"2025121807520361800_R4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00003086-198807000-00006","article-title":"A new periacetabular osteotomy for the treatment of hip dysplasias. Technique and preliminary results","volume":"232","author":"Ganz","year":"1988","journal-title":"Clin Orthop Relat Res"},{"key":"2025121807520361800_R5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2106\/00004623-198466030-00017","article-title":"Rotational acetabular osteotomy for the dysplastic hip","volume":"66","author":"Ninomiya","year":"1984","journal-title":"J Bone Joint Surg Am"},{"key":"2025121807520361800_R6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.arthro.2012.04.148","article-title":"Platelet-rich plasma: the PAW classification system","volume":"28","author":"DeLong","year":"2012","journal-title":"Arthroscopy"},{"key":"2025121807520361800_R7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/ard.2004.022905","article-title":"Evaluation of clinically relevant changes in patient-reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement","volume":"64","author":"Tubach","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2025121807520361800_R8","doi-asserted-by":"publisher","DOI":"10.1186\/ar4493","article-title":"Biology of platelet-rich plasma and its clinical application in cartilage repair","volume":"16","author":"Xie","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025121807520361800_R9","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.joca.2006.05.008","article-title":"Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis","volume":"14","author":"Akeda","year":"2006","journal-title":"Osteoarthr Cartil"},{"key":"2025121807520361800_R10","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/rheumatology\/kem234","article-title":"Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients","volume":"46","author":"Anitua","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2025121807520361800_R11","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1177\/0363546511419278","article-title":"Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes","volume":"39","author":"van Buul","year":"2011","journal-title":"Am J Sports Med"},{"key":"2025121807520361800_R12","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1177\/0363546520924011","article-title":"Intra-articular injection of pure platelet-rich plasma is the most effective treatment for joint pain by modulating synovial inflammation and calcitonin gene-related peptide expression in a rat arthritis model","volume":"48","author":"Araya","year":"2020","journal-title":"Am J Sports Med"},{"key":"2025121807520361800_R13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1177\/0363546515620383","article-title":"Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid in hip osteoarthritis: a randomized controlled study","volume":"44","author":"Dallari","year":"2016","journal-title":"Am J Sports Med"},{"key":"2025121807520361800_R14","doi-asserted-by":"publisher","DOI":"10.1177\/2325967120969219","article-title":"Comparing intra-articular injections of leukocyte-poor platelet-rich plasma versus low\u2013molecular weight hyaluronic acid for the treatment of symptomatic osteoarthritis of the hip: a double-blind, randomized pilot study","volume":"9","author":"Kraeutler","year":"2021","journal-title":"Orthop J Sports Med"},{"issue":"4","key":"2025121807520361800_R15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.11152\/mu-874","article-title":"Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis","volume":"18","author":"Sante","year":"2016","journal-title":"Medical Ultrasonography"},{"key":"2025121807520361800_R16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijsu.2018.03.078","article-title":"Platelet-rich plasma versus hyaluronic acid in patients with hip osteoarthritis: a meta-analysis of randomized controlled trials","volume":"53","author":"Ye","year":"2018","journal-title":"Int J Surg"},{"key":"2025121807520361800_R17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10067-020-05241-x","article-title":"Effectiveness of platelet-rich plasma in the management of hip osteoarthritis: a systematic review and meta-analysis","volume":"40","author":"Medina-Porqueres","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025121807520361800_R18","doi-asserted-by":"publisher","DOI":"10.1177\/2325967120960414","article-title":"Preparation methods and clinical outcomes of platelet-rich plasma for intra-articular hip disorders: a systematic review and meta-analysis of randomized clinical trials","volume":"8","author":"Garc\u00eda","year":"2020","journal-title":"Orthop J Sports Med"},{"key":"2025121807520361800_R19","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1007\/s11999-012-2386-4","article-title":"What is the frequency of conversion to THA after periacetabular osteotomy?","volume":"470","author":"Hartig-Andreasen","year":"2012","journal-title":"Clin Orthop Relat Res"},{"key":"2025121807520361800_R20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/bjsports-2020-102179","article-title":"Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomized controlled trials","volume":"55","author":"Gazendam","year":"2021","journal-title":"Br J Sports Med"}],"container-title":["Journal of Hip Preservation Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jhps\/article-pdf\/12\/4\/230\/62308337\/hnaf008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jhps\/article-pdf\/12\/4\/230\/62308337\/hnaf008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:52:09Z","timestamp":1766062329000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jhps\/article\/12\/4\/230\/8058728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,3,5]]},"published-print":{"date-parts":[[2025,12,18]]}},"URL":"https:\/\/doi.org\/10.1093\/jhps\/hnaf008","relation":{},"ISSN":["2054-8397"],"issn-type":[{"value":"2054-8397","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,3,5]]}}}